Previously, Repatha was indicated to reduce the risk of MACE in patients with established cardiovascular disease. The Food and Drug Administration (FDA) has expanded the approval of Repatha ® ...
The FDA expanded Repatha's label to include adults at increased risk for MACE due to uncontrolled LDL-C, broadening access beyond those with diagnosed CVD. Repatha is now approved as a standalone ...
Repatha (evolocumab) is an injectable medicine that helps lower levels of low-density lipoprotein cholesterol (LDL), often called “bad” cholesterol. Approved in 2015, Repatha can now be used in adults ...
THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has broadened the approved use of Repatha ® (evolocumab) to ...
Amgen, a biotechnology company that discovers, develops, manufactures and delivers innovative medicines, announced that the US Food and Drug Administration (FDA) has broadened the approved use of ...
THOUSAND OAKS, Calif. - The U.S. Food and Drug Administration has broadened the approved use of Amgen’s (NASDAQ:AMGN) Repatha to include adults at increased risk for major adverse cardiovascular ...
Founded by former OpenAI staff members and funded by Amazon and Google, Anthropic has raised the stakes in the GPT wars. Anthropic's Claude Desktop app often outshines its ChatGPT rival in various ...
The Association of Tutorial School Operators has suspended the Secretary of its Oyo State chapter, Ogundokun Olufunso, for calling for a five-year single term for registrars of the Joint Admissions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback